Immunogenicity is a measure of the immune response to a biotherapeutic drug. It is a very relevant issue affecting not only the use of therapeutic protein drugs such as mAbs but also peptides, enzymes ...

Assessing immunogenicity is a cornerstone of modern drug development, especially for biologics and vaccines. Understanding how the immune system interacts with therapeutic agents is essential to ...

A drug-induced immune response can significantly alter the safety and efficacy of biotherapeutic drugs. Hence, early testing and prediction of potential immunogenicity and allergenicity caused by ...

BALTIMORE--(BUSINESS WIRE)--Sapio Sciences, the science-aware™ lab informatics platform, today announced the addition of new immunogenicity bioanalysis features to its industry-leading lab informatics ...

Assessment of immunogenicity is an important component of drug safety evaluation in preclinical, clinical and postmarketing studies. Biopharmaceuticals currently employed in the clinic exhibit various ...

The use of biologic-based therapeutics has revolutionized our ability to treat complex diseases such as cancer- and autoimmune-related disorders. Biologic-based therapeutics are known to generate anti ...

USP Seeks Input on Recently Introduced Set of Best Practices for ADA Screening Activities Biologic drugs have revolutionized the treatment of many chronic diseases. Used to treat certain cancers, ...

This is a preview. Log in through your library . Journal Information Founded in 1904, The Journal of Infectious Diseases is the premier publication in the Western Hemisphere for original research on ...

In a recent article published in Nature Communications, researchers reported a proteogenomic approach to investigate fresh solid melanoma tumor material. The approach combines liquid ...